Jazz Pharmaceuticals Plc (JAZZ)
254.34
+0.06
(+0.02%)
USD |
NASDAQ |
Aug 24, 16:00
257.70
+3.36
(+1.32%)
After-Hours: 20:00
Jazz Pharmaceuticals Debt to Equity Ratio : 0.9183 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.9183 |
| March 31, 2026 | 1.195 |
| December 31, 2025 | 1.257 |
| September 30, 2025 | 1.371 |
| June 30, 2025 | 1.466 |
| March 31, 2025 | 1.298 |
| December 31, 2024 | 1.506 |
| September 30, 2024 | 1.487 |
| June 30, 2024 | 1.539 |
| March 31, 2024 | 1.565 |
| December 31, 2023 | 1.551 |
| September 30, 2023 | 1.660 |
| June 30, 2023 | 1.645 |
| March 31, 2023 | 1.742 |
| December 31, 2022 | 1.885 |
| September 30, 2022 | 2.118 |
| June 30, 2022 | 1.910 |
| March 31, 2022 | 1.697 |
| December 31, 2021 | 1.553 |
| September 30, 2021 | 1.623 |
| June 30, 2021 | 1.675 |
| March 31, 2021 | 0.5929 |
| December 31, 2020 | 0.6146 |
| September 30, 2020 | 0.6641 |
| June 30, 2020 | 0.7194 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.6302 |
| December 31, 2019 | 0.5693 |
| September 30, 2019 | 0.5793 |
| June 30, 2019 | 0.592 |
| March 31, 2019 | 0.6451 |
| December 31, 2018 | 0.579 |
| September 30, 2018 | 0.5265 |
| June 30, 2018 | 0.5546 |
| March 31, 2018 | 0.5678 |
| December 31, 2017 | 0.5827 |
| September 30, 2017 | 0.6398 |
| June 30, 2017 | 0.7596 |
| March 31, 2017 | 0.9454 |
| December 31, 2016 | 1.081 |
| September 30, 2016 | 1.272 |
| June 30, 2016 | 0.6967 |
| March 31, 2016 | 0.7366 |
| December 31, 2015 | 0.7434 |
| September 30, 2015 | 0.8249 |
| June 30, 2015 | 0.9445 |
| March 31, 2015 | 1.030 |
| December 31, 2014 | 0.9791 |
| September 30, 2014 | 1.000 |
| June 30, 2014 | 0.9349 |
| March 31, 2014 | 0.9597 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Avadel Pharmaceuticals Plc | -- |
| Perrigo Co. Plc | 1.375 |
| GH Research Plc | 0.001 |
| Cosmo NV | -- |
| Liquidia Corp. | 0.9374 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 11.08B |
| Total Liabilities (Quarterly) | 6.279B |
| Shareholders Equity (Quarterly) | 4.802B |
| Current Ratio | 1.779 |
| Net Debt Paydown Yield | 1.29% |